420 related articles for article (PubMed ID: 16842857)
41. SHIP2 multiple functions: a balance between a negative control of PtdIns(3,4,5)P₃ level, a positive control of PtdIns(3,4)P₂ production, and intrinsic docking properties.
Erneux C; Edimo WE; Deneubourg L; Pirson I
J Cell Biochem; 2011 Sep; 112(9):2203-9. PubMed ID: 21503961
[TBL] [Abstract][Full Text] [Related]
42. Ebselen enhances insulin sensitivity and decreases oxidative stress by inhibiting SHIP2 and protects from inflammation in diabetic mice.
Polianskyte-Prause Z; Tolvanen TA; Lindfors S; Kon K; Hautala LC; Wang H; Wada T; Tsuneki H; Sasaoka T; Lehtonen S
Int J Biol Sci; 2022; 18(5):1852-1864. PubMed ID: 35342343
[TBL] [Abstract][Full Text] [Related]
43. Developmental defects and rescue from glucose intolerance of a catalytically-inactive novel Ship2 mutant mouse.
Dubois E; Jacoby M; Blockmans M; Pernot E; Schiffmann SN; Foukas LC; Henquin JC; Vanhaesebroeck B; Erneux C; Schurmans S
Cell Signal; 2012 Nov; 24(11):1971-80. PubMed ID: 22750293
[TBL] [Abstract][Full Text] [Related]
44. PTEN and SHIP2 phosphoinositide phosphatases as negative regulators of insulin signalling.
Vinciguerra M; Foti M
Arch Physiol Biochem; 2006 Apr; 112(2):89-104. PubMed ID: 16931451
[TBL] [Abstract][Full Text] [Related]
45. The lipid phosphatase SHIP2 controls insulin sensitivity.
Clément S; Krause U; Desmedt F; Tanti JF; Behrends J; Pesesse X; Sasaki T; Penninger J; Doherty M; Malaisse W; Dumont JE; Le Marchand-Brustel Y; Erneux C; Hue L; Schurmans S
Nature; 2001 Jan; 409(6816):92-7. PubMed ID: 11343120
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of 11β-hydroxysteroid dehydrogenase 1 by carbenoxolone affects glucose homeostasis and obesity in db/db mice.
Dhanesha N; Joharapurkar A; Shah G; Kshirsagar S; Dhote V; Sharma A; Jain M
Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):69-77. PubMed ID: 22060140
[TBL] [Abstract][Full Text] [Related]
47. Regulation of endogenous SH2 domain-containing inositol 5-phosphatase (SHIP2) in 3T3-L1 and human preadipocytes.
Gagnon A; Artemenko Y; Crapper T; Sorisky A
J Cell Physiol; 2003 Nov; 197(2):243-50. PubMed ID: 14502564
[TBL] [Abstract][Full Text] [Related]
48. SH2-containing inositol 5'-phosphatase 2 selectively impairs hypothalamic insulin signalling and regulation of food intake in mice.
Ichihara Y; Wada T; Soeda Y; Ishii Y; Sasahara M; Tsuneki H; Sasaoka T
J Neuroendocrinol; 2013 Apr; 25(4):372-82. PubMed ID: 23286299
[TBL] [Abstract][Full Text] [Related]
49. Phosphatidylinositol 3,4,5-trisphosphate modulation in SHIP2-deficient mouse embryonic fibroblasts.
Blero D; Zhang J; Pesesse X; Payrastre B; Dumont JE; Schurmans S; Erneux C
FEBS J; 2005 May; 272(10):2512-22. PubMed ID: 15885100
[TBL] [Abstract][Full Text] [Related]
50. SHIPping out diabetes-Metformin, an old friend among new SHIP2 inhibitors.
Lehtonen S
Acta Physiol (Oxf); 2020 Jan; 228(1):e13349. PubMed ID: 31342643
[TBL] [Abstract][Full Text] [Related]
51. Phosphoinositol phosphatase SHIP2 promotes cancer development and metastasis coupled with alterations in EGF receptor turnover.
Prasad NK; Tandon M; Badve S; Snyder PW; Nakshatri H
Carcinogenesis; 2008 Jan; 29(1):25-34. PubMed ID: 17893231
[TBL] [Abstract][Full Text] [Related]
52. ["SHIP2 and insulin signaling: what is its role in the pathogenesis and treatment of type 2 diabetes?"].
Schurmans S
Bull Mem Acad R Med Belg; 2003; 158(7-9):335-9; discussion 340. PubMed ID: 15132004
[TBL] [Abstract][Full Text] [Related]
53. Serum withdrawal-induced accumulation of phosphoinositide 3-kinase lipids in differentiating 3T3-L6 myoblasts: distinct roles for Ship2 and PTEN.
Mandl A; Sarkes D; Carricaburu V; Jung V; Rameh L
Mol Cell Biol; 2007 Dec; 27(23):8098-112. PubMed ID: 17893321
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of endogenous SHIP2 ameliorates insulin resistance caused by chronic insulin treatment in 3T3-L1 adipocytes.
Sasaoka T; Fukui K; Wada T; Murakami S; Kawahara J; Ishihara H; Funaki M; Asano T; Kobayashi M
Diabetologia; 2005 Feb; 48(2):336-44. PubMed ID: 15654601
[TBL] [Abstract][Full Text] [Related]
55. Association of the polymorphisms in the 5'-untranslated region of PTEN gene with type 2 diabetes in a Japanese population.
Ishihara H; Sasaoka T; Kagawa S; Murakami S; Fukui K; Kawagishi Y; Yamazaki K; Sato A; Iwata M; Urakaze M; Ishiki M; Wada T; Yaguchi S; Tsuneki H; Kimura I; Kobayashi M
FEBS Lett; 2003 Nov; 554(3):450-4. PubMed ID: 14623110
[TBL] [Abstract][Full Text] [Related]
56. Regulation of PDGF-stimulated SHIP2 tyrosine phosphorylation and association with Shc in 3T3-L1 preadipocytes.
Artemenko Y; Gagnon A; Ibrahim S; Sorisky A
J Cell Physiol; 2007 Jun; 211(3):598-607. PubMed ID: 17219406
[TBL] [Abstract][Full Text] [Related]
57. The SH2 domain containing inositol 5-phosphatase SHIP2 controls phosphatidylinositol 3,4,5-trisphosphate levels in CHO-IR cells stimulated by insulin.
Blero D; De Smedt F; Pesesse X; Paternotte N; Moreau C; Payrastre B; Erneux C
Biochem Biophys Res Commun; 2001 Apr; 282(3):839-43. PubMed ID: 11401540
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of SH2-domain-containing inositol 5-phosphatase (SHIP2) ameliorates palmitate induced-apoptosis through regulating Akt/FOXO1 pathway and ROS production in HepG2 cells.
Gorgani-Firuzjaee S; Adeli K; Meshkani R
Biochem Biophys Res Commun; 2015 Aug; 464(2):441-6. PubMed ID: 26123392
[TBL] [Abstract][Full Text] [Related]
59. Rational design and synthesis of 4-substituted 2-pyridin-2-ylamides with inhibitory effects on SH2 domain-containing inositol 5'-phosphatase 2 (SHIP2).
Ichihara Y; Fujimura R; Tsuneki H; Wada T; Okamoto K; Gouda H; Hirono S; Sugimoto K; Matsuya Y; Sasaoka T; Toyooka N
Eur J Med Chem; 2013 Apr; 62():649-60. PubMed ID: 23434638
[TBL] [Abstract][Full Text] [Related]
60. Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity.
Sleeman MW; Wortley KE; Lai KM; Gowen LC; Kintner J; Kline WO; Garcia K; Stitt TN; Yancopoulos GD; Wiegand SJ; Glass DJ
Nat Med; 2005 Feb; 11(2):199-205. PubMed ID: 15654325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
